Scherzer R, et. al. A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans. AIDS 2014; 28:9, 1289–1295.

Scherzer R, Shlipak MG. Risk factors: Individual assessment of CKD risk in HIV-positive patients. Nat Rev Nephrol. 2015 Jul;11(7):392-3. doi: 10.1038/nrneph.2015.75. Epub 2015 May 12.

Dr. Rebecca Scherzer

CKD Prediction in HIV+ Patients

gluc

proturia

tenofivir

<p>Determines probability of HIV patients developing CKD in the next 5 years, if they take tenofivir or not.</p>

HIV CKD Prediction

The CKD Prediction in HIV+ Patients determines probability of HIV patients developing CKD in the next 5 years, if they take tenofivir or not.

FIB-4 Index

VACS 1.0 Index

VACS 2.0 Index

EB Medicine is the premier provider of evidence-based clinical content and CME resources for emergency medicine practitioners.

Listen to the VACO co-creators break down how to use VACO\, what it does\, and what it doesn’t.

Calc Function